Rucaparib in Men with Metastatic Castration-Resistant Prostate Cancer A Journal Club on the TRITON 2 Study – Christopher Wallis & Zachary Klaassen

Rucaparib was evaluated as a treatment for men with metastatic castration-resistant prostate cancer (mCRPC) associated with a BRCA gene alteration who had received prior taxane and androgen receptor–directed therapy. In this UroToday Journal Club, Christopher Wallis and Zachary Klaassen discuss the clinical rationale which led to the exploration of PARP inhibitors in men with advanced prostate…

Read the full article here

Source: UroToday

Categories: General Medicine News, Latest Headlines

Tags: JournalClub, ProstateCancer, TRITON2, WatchNow

Tweets with this article

UroToday.com

Rucaparib in men with metastatic castration-resistant #ProstateCancer. A #JournalClub review on the #TRITON2 study. #WatchNow on UroToday > https://t.co/bNl3h03Atu @WallisCJD @VUMCurology & @zklaassen_md @GACancerCenter @ASCO_pubs https://t.co/bpxq4V46TR

Managing Nonmetastatic Castration-Resistant Prostate Cancer – Zachary Reardon

Zach Klaassen and Zach Reardon delve into the nuances of managing nonmetastatic castration-resistant prostate cancer (nmCRPC) in clinical practice. Dr. Reardon discusses the evolving landscape…

UroToday.com May 8, 2024

State of the Art and Future Challenges of Urethra-Sparing Stereotactic Body Radiotherapy for Prostate Cancer: A Systematic Review of Literature – Beyond the Abstract

Prostate cancer, stereotactic body radiotherapy (SBRT), Urethra-Sparing Stereotactic Body Radiotherapy, Urethra-Sparing Stereotactic Body Radiotherapy for Prostate Cancer, magnetic resonance guided radiotherapy (MRgRT).

UroToday.com May 7, 2024

Comparing Cost-Effectiveness of Surgery, Radiation, and Chemo for Seminoma – Daniel Joyce

Ruchika Talwar interviews Daniel Joyce about his journey into cost-effectiveness studies, particularly in testicular cancer. Initially skeptical, Dr. Joyce now sees these studies as crucial…

UroToday.com May 7, 2024

ARASENS Subgroup Analysis on Triplet Therapy Improves Outcomes for Black Patients with mHSPC, Journal Club – Rashid Sayyid & Zachary Klaassen

Rashid Sayyid and Zach Klaassen delve into the significance of racial disparities in prostate cancer treatment through a subgroup analysis of the ARASENS trial, which…

UroToday.com May 7, 2024

The Use of Imaging in Staging Localized Prostate Cancer: A Case Study on High-Risk Localized Prostate Cancer – Zachary Klaassen

Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Zachary…

UroToday.com May 7, 2024

The Impact of Advanced Imaging on Detection and Treatment in Nonmetastatic CRPC – Vahan Kassabian

Zach Klaassen engages in a discussion with Vahan Kassabian about the evolving landscape of nonmetastatic castration-resistant prostate cancer (nmCRPC) management. They delve into how novel…

UroToday.com May 7, 2024

PIVOT-006 – A Study of Intravesical Cretostimogene Grenadenorepvec for Treatment of Patients with Intermediate-Risk, Non-Muscle Invasive Bladder Cancer – Mark Tyson

Ashish Kamat and Mark Tyson discuss the currently enrolling PIVOT-006 study. Dr. Tyson discusses cretostimogene grenadenorepvec, a conditionally replicating oncolytic adenovirus designed for cancer cell…

UroToday.com May 7, 2024

Apalutamide plus Androgen Deprivation Therapy in Clinical Subgroups of Patients with Metastatic Castration-Sensitive Prostate Cancer: A Subgroup Analysis of the Randomised Clinical TITAN Study – Beyond the Abstract

metastatic castration-sensitive prostate cancer (mCSPC), apalutamide treatment effect in TITAN patients with mCSPC, phase III randomised TITAN study, robust benefit with apalutamide plus ADT.

UroToday.com May 7, 2024

Drug Shortages: Why Are They a Recurrent Issue and What Can Regulatory Do to Prevent Them? – Chana Weinstock

Ruchika Talwar speaks with Chana Weinstock about the recent chemotherapy shortage affecting genitourinary cancers, notably muscle-invasive bladder cancer. Dr. Weinstock explains the complexity behind drug…

UroToday.com May 7, 2024

Robot-Assisted PSMA-Radioguided Surgery to Assess Surgical Margins and Nodal Metastases in Prostate Cancer Patients: Report on Three Cases Using an Intraoperative PET-CT Specimen Imager – Beyond the Abstract

Robot-Assisted PSMA-Radioguided Surgery, Prostate Cancer, radical prostatectomy, Confocal microscopy, PSMA PET/CT, 68Ga-PSMA-11, robot-assisted radical prostatectomy (RARP), pelvic lymph node dissection (PLND), AURA 10 specimen PET/CT…

UroToday.com May 7, 2024

Related Articles